AB-204-NA; 20 µg/mL) and 10 ng/mL Recombinant Human IL-12 (Catalog #
219-IL) for 5 days to induce Th1 cell development were stained with (A) Mouse Anti-Human CXCR6 Monoclonal Antibody (Catalog # MAB6991) or (B) Isotype control antibody (Catalog #
MAB003) followed by Phycoerythrin-conjugated Anti-Mouse IgG Secondary Antibody (Catalog #
F0102B) and Mouse Anti-Human CD4 APC-conjugated Monoclonal Antibody (Catalog #
FAB3791A). View our protocol for
Staining Membrane-associated Proteins." class="big_lightbox">

AB-204-NA; 20 µg/mL) and 10 ng/mL Recombinant Human IL-12 (Catalog #
219-IL) for 5 days to induce Th1 cell development were stained with (A) Mouse Anti-Human CXCR6 Monoclonal Antibody (Catalog # MAB6991) or (B) Isotype control antibody (Catalog #
MAB003) followed by Phycoerythrin-conjugated Anti-Mouse IgG Secondary Antibody (Catalog #
F0102B) and Mouse Anti-Human CD4 APC-conjugated Monoclonal Antibody (Catalog #
FAB3791A). View our protocol for
Staining Membrane-associated Proteins." alt="Human CD3
+peripheral blood mononuclear cells (PBMCs) cultured with plate bound anti-Human CD3 and CD28 Antibodies, Anti-Human IL-4 Polyclonal Antibody (Catalog #
AB-204-NA; 20 µg/mL) and 10 ng/mL Recombinant Human IL-12 (Catalog #
219-IL) for 5 days to induce Th1 cell development were stained with (A) Mouse Anti-Human CXCR6 Monoclonal Antibody (Catalog # MAB6991) or (B) Isotype control antibody (Catalog #
MAB003) followed by Phycoerythrin-conjugated Anti-Mouse IgG Secondary Antibody (Catalog #
F0102B) and Mouse Anti-Human CD4 APC-conjugated Monoclonal Antibody (Catalog #
FAB3791A). View our protocol for
Staining Membrane-associated Proteins." class="big_thumb" />